BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
   

Fibrocell Science, Inc. Announces Second Quarter 2012 LAVIV Order Information


7/17/2012 10:06:39 AM

EXTON, Pa.--(BUSINESS WIRE)--Fibrocell Science, Inc. (OTCBB: FCSC), announced today its LAVIV order information for the second quarter ended June 30, 2012. During the second quarter of 2012, Fibrocell received orders for 387 biopsies, an increase of 104% as compared to 189 orders during the first quarter of 2012. During the second quarter of 2012, 85 new physicians placed orders for biopsies, an increase of 60% as compared to 53 new physicians during the first quarter of 2012. During the second quarter of 2012, 39 physicians placed repeat orders for biopsies, an increase of 200% as compared to 13 physicians during the first quarter of 2012. Since the launch of LAVIV in June 2011, Fibrocell has received 706 biopsy orders from 162 physicians.

Read at BioSpace.com


   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES
 

//-->